Quick Answer
MEDICINOVA INC reported Revenue (ASC 606) of $409.7 thousand for fiscal year 2025.
MEDICINOVA INC Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $409.7K | -59.0% |
| 2023 | $1.00M | -75.2% |
| 2021 | $4.04M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $123.3K | — | -8.4% |
| June 30, 2025 | $134.6K | — | -86.5% |
| September 30, 2023 | $1.00M | — | +2566.7% |
| September 30, 2021 | $37.5K | — | -99.1% |
| March 31, 2021 | $4.00M | — | — |
- MEDICINOVA INC showed a decrease of -59.0% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2021–2025 period, MEDICINOVA INC’s revenue (asc 606) has declined by 89.9% (from $4.04 million to $409.7 thousand).
- The most recent figure is from MEDICINOVA INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: